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Jatropha curcas seed cake is a low-value by-product resulting from biodiesel production.
The seed cake is highly toxic, but it has great potential for biotechnology applications
as it is a repository of biomolecules that could be important in agriculture, medicine,
and industry. To explore this potential, a novel trypsin inhibitor called JcTI-I was puriﬁed
by fractionation of the crude extract with trichloroacetic acid (2.5%, v/v) followed by
afﬁnity chromatography (Trypsin-Sepharose 4B) andmolecular exclusion (Sephacryl S-200).
Non-reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis and gel ﬁltration
showed that JcTI-I has approximately 20.0 kDa. Mass spectrometry analysis revealed that
the intact molecular mass of JcTI-I is 10.252 kDa. Moreover, JcTI-I is a glycoprotein with
6.4% (m/m) carbohydrates, pI of 6.6, N-terminal sequence similarity around 60% to plant
albumins and high stability to heat, pH, and salinity. JcTI-I presented antibacterial activity
against the human pathogenic bacteria Salmonella enterica subspecies enterica serovar
choleraesuis and Staphylococcus aureus, with minimum inhibitory concentration less than
5 μg/mL. Furthermore, JcTI-I did have inhibitory activity against the serine proteases from
the tested bacteria. Otherwise, no hemolytic activity of human erythrocytes and signs
of acute toxicity to mice were observed for JcTI-I. The results demonstrate the beneﬁts
of J. curcas seed cake as a source of trypsin inhibitor with potential for biotechnological
application as a new antimicrobial agent against human pathogenic bacteria.
Keywords: Jatropha curcas, seed cake, serine proteinase inhibitor, trypsin inhibitor, bacterial infections,
antimicrobial agent
INTRODUCTION
Hospital-acquired infection is the major cause of death in crit-
ically ill patients, both in developing and developed countries
(Ramsamy et al., 2013). These infections are a challenge to
patient safety because the causal agents have developed antibiotic-
resistance, thus limiting treatment options (Mulvey and Simor,
2009; Becker et al., 2012). For example, both the methicillin-
resistant Staphylococcus aureus (MRSA) and multidrug-resistant
Salmonella enterica are the principal multidrug resistant bacterial
pathogens that cause serious community and hospital-acquired
infections, responsible for high annual health care costs and psy-
chological stress associated with social stigma (Cosgrove et al.,
2003; Brydon et al., 2009; Broughton et al., 2010). Therefore effec-
tive new therapeutic agents with novel mechanisms of action
for treatment of infections caused by multidrug resistant bac-
teria are urgently needed (Hughes et al., 2012). In this context,
as plants have numerous therapeutic compounds they consti-
tute natural targets from which new antibacterial drugs with high
efﬁcacy and less toxicity can be developed to treat infectious dis-
eases (Ngo et al., 2013). Indeed, biologically active compounds
from plant resources have been extracted from different species
(Savoia, 2012).
Jatropha curcas, also known as physic nut, is a shrub belonging
to the Euphorbiaceae family. This species is highly adaptable to
adverse conditions and is resistant to many pests and pathogens
(Debnath and Bisen, 2008; Sabandar et al., 2013). In addition,
J. curcas seeds constitute an oil-rich plant source from which
biodiesel is produced (Rashid et al., 2010). After oil extraction
by screw press, the remaining seed cake is highly toxic to a num-
ber of animal species, probably due to the presence of phorbol
esters and curcin, a type-I ribosome inactivating protein (Goel
et al., 2007; Zhao et al., 2012). Protease inhibitor, lectin, and
phytate are also present in high amounts (Saetae and Suntorn-
suk, 2011). Nevertheless, these compounds could be isolated
and characterized to exploit their possible medicinal applica-
tions, as it was suggested that the J. curcas seed cake could
be utilized as a source of antibacterial and antifungal agents
(Sundari and Selvaraj, 2011).
Among these various molecules present in J. curcas seed cake,
the protease inhibitors could be a potentially novel class of antimi-
crobial agents, as they speciﬁcally inhibit the catalytic action of
enzymes by formation of stoichiometric complex with the tar-
get enzymes, blocking or altering its active site (Kim et al., 2009;
Volpicella et al., 2011). In fact, protease inhibitors are found to
be involved in various important physiological functions like
regulators of endogenous proteinases and defense mechanism
(Bhattacharjee et al., 2012). However, protease inhibitors also
have received new interest due to their biological properties with
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potential for use as clinical agents. Of importance in the context
of seeking plant protease inhibitors as novel therapeutic agents
is that Xb-KTI, a Kunitz trypsin inhibitor present in Xanthosoma
blandum corms with bactericidal activity (Lima et al., 2011). Simi-
larly, the ﬁstulin, a naturally occurring inhibitor of serine protease
present in Cassia ﬁstula leaves, showed to be very active against
several pathogenic bacterial strains, namely, Staphylococcus aureus,
Escherichia coli,Bacillus subtilis, and Klebsiella pneumoniae, and its
efﬁcacy was comparable to the standard drug, streptomycin sulfate
(Arulpandi and Sangeetha, 2012).
To the best of our knowledge, a trypsin inhibitor from J. curcas
seed cake has never been isolated neither its antibacterial activity
tested yet. Thus, the present paper describes the puriﬁcation and
physicochemical characterization of a novel trypsin inhibitor from
J. curcas seed cake, designated JcTI-I. Additionally, to gain better
insights on the biological activity of this protein and to devise
future use as a new therapeutic drugs, its inhibitory activity against
the growth of the human pathogen bacteria Staphylococcus aureus
and Salmonella enterica, as well as the ability of JcTI-I to inhibit
the bacterial proteases were evaluated.
MATERIALS AND METHODS
MATERIALS
Jatropha curcas seed cake was obtained from Instituto Fazenda
Tamanduá (Paraíba, Brazil), grounded in a coffee grinder and
passed through a 1-mm-mesh screen. The resulting ﬂour was
treated with n-hexane (1:5, m/v) to remove the remaining oil left
after biodiesel extraction. Defatted ﬂour was stored in air-tight
containers at 4◦C until analysis. The bacteria Salmonella enterica
subspecies enterica serovar choleraesuis (ATCC 10708), Bacillus
subtilis subspecies spizizenii (ATCC 6633), Pseudomonas aerug-
inosa (ATCC 25619), and Staphylococcus aureus (ATCC 25923)
were obtained from the Department of Biology (UFC), Fortaleza,
Brazil. Swiss mice (Mus musculus), 20–25 g, were from the ani-
mal house at UFC. Azocasein, bovine pancreatic trypsin, bovine
pancreatic chymotrypsin, bovine serum albumin (BSA), soybean
trypsin inhibitor (SBTI),Nα-benzoyl-D,L-arginina-p-naftilamida
(BANA),4-(dimethylamino)cinnamaldehyde (DMACA),ethylene-
diaminetetraacetic acid (EDTA), phenylmethylsulfonyl ﬂuoride
(PMSF), L-cysteine and Nα-benzoyl-D,L-arginine 4-nitroanilide
hydrochloride (BAPNA), sodium dodecyl sulfate (SDS), molar
mass markers, acrylamide, bis-acrylamide, dithiothreitol (DTT)
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Chromatographic matrixes were from GE Healthcare. All other
chemicals and reagents used were of analytical grade.
PROTEIN DETERMINATION
The method described by Bradford (1976) was used with BSA
as standard. Absorbance at 280 nm was also used to detect the
presence of protein in the chromatographic eluates.
TRYPSIN INHIBITION ASSAY
Trypsin inhibitory activity against bovine trypsin (EC 3.4.21.4)
was performed as described by Erlanger et al. (1961) using the
chromogenic substrate BAPNA. The enzyme concentration used
was established based on a dependent concentration assay and
was that producing an absorbance between 0.25 and 0.30 in the
enzymatic assay and reaction rate corresponding to ½Vmax. The
inhibitory assay mixture consisted of 100 μL of crude extract
(4.74 mg/mL) or the puriﬁed inhibitor (0.03 mg/mL) dissolved
in distilled water, incubated with 10 μL of trypsin (0.3 mg/mL
in 10−3 M HCl) and 690 μL of 0.05 M Tris–HCl/0.02 M CaCl2,
pH 7.5, at 37◦C for 10 min. Next, 500 μL of 1.25 × 10−3 M
BAPNA dissolved in the above buffer were added and the mix-
ture further incubated for 15 min, 37◦C. Reaction was stopped
by addition of 120 μL of 30% (v/v) acetic acid. The enzy-
matic activities in the absence and presence of the inhibitor
were evaluated by p-nitroanilide release from BAPNA mea-
sured at 410 nm using a Biochrom Libra S-12 spectrophotome-
ter. One trypsin inhibitory activity unit (TIU) was deﬁned as
the decrease in 0.01 U of absorbance per 15 min assay, at
37◦C. Appropriate blanks for the enzyme, inhibitor and the
substrate were also included in the assay along with the test
samples.
PREPARATION OF THE PROTEIN EXTRACT
Defatted ﬂour was extracted with 0.1 M borate buffer, pH 10.0, in
a proportion of 1.0 g of meal to 10.0 mL of buffer for 2 h under
sonication, at 4◦C. Next the suspension was maintained under
constant stirring for 2 h at 4◦C and ﬁltered through cheesecloth.
The ﬁltrate was centrifuged at 10,000 × g, 4◦C, 30 min and the
clear supernatant, denoted crude extract, was dialyzed (cut-off
12 kDa) against 0.050 M sodium phosphate buffer, pH 7.5. The
protein content and trypsin inhibitory activity of this dialyzed
extract were determined and it was further used for puriﬁcation
of the trypsin inhibitor as described below.
PURIFICATION OF J. curcas TRYPSIN INHIBITOR
The crude extract prepared as described in Section “protein
Determination” was fractionated by precipitation with 2.5%
(v/v) trichloroacetic acid (TCA) ﬁnal concentration, at 4◦C
and centrifuged at 14,000 × g, 4◦C, 30 min. The clear
supernatant obtained was dialyzed exhaustively against water
(Milli-Q grade), lyophilized, and assayed for antitrypsin activ-
ity. The TCA fraction (30 mg) was dissolved in 0.050 M
sodium phosphate buffer/0.2 M NaCl, pH 7.5 and applied to
a trypsin-Sepharose 4B column (11.5 cm × 2.2 cm) equili-
brated with the above buffer. After complete removal of the
non-retained proteins with the equilibrating buffer, the pro-
teins bound to the immobilized trypsin were eluted with 0.1 M
HCl, dialyzed exhaustively against water (Milli-Q grade) and
lyophilized. This material (2 mg) was loaded on a Sephacryl
S-200 column connected to an ÄKTA-Prime System (GE Health-
care) previously equilibrated and eluted with 0.050 M sodium
phosphate buffer/0.2 M NaCl, pH 7.5. Fractions (1 mL)
were eluted at the ﬂow rate of 0.5 mL/min and the protein
fractions obtained evaluated for trypsin inhibitory activity as
described before. The puriﬁed trypsin inhibitor was named JcTI-I
(J. curcas Trypsin Inhibitor I).
CHARACTERIZATION OF JcTI-I
Molecular mass determination
The apparent molecular mass of JcTI-I was determined by dena-
turing electrophoresis [SDS-polyacrylamide gel electrophoresis
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(SDS-PAGE); Laemmli, 1970], in 12.5% (m/v) polyacrylamide
gels (10 cm × 8 cm). Samples were prepared in 0.5 M Tris–HCl
buffer, pH 6.8, containing 1% SDS, in the presence or absence
of 1% β-mercaptoethanol and boiled at 98◦C, for 5 min, before
electrophoresis, which was performed at 20 mA. Protein bands
were stained with Coomassie Brilliant Blue G-250 (Candiano
et al., 2004). The native molecular mass of JcTI-I (3 mg) was
determined by gel ﬁltration on Sephacryl S-200 column, cou-
pled to an ÄKTA-Prime System (GE Healthcare) and equilibrated
with 0.050 M sodium phosphate buffer/0.2 M NaCl, pH 7.5.
Chromatography was carried out at a constant ﬂow rate of
0.5 mL/min and 1 mL fractions were collected. Before load-
ing on the column, the sample was centrifuged at 14,000 × g,
4◦C, for 5 min and the supernatant ﬁltered through a Pro-X
TM ﬁlter unit (0.22 mm hydrophilic cellulose acetate mem-
brane). The column was previously calibrated with proteins of
known molecular mass (BSA, 66 kDa; egg albumin, 45 kDa; chy-
motrypsinogen, 25 kDa; ribonuclease, 13.7 kDa, and aprotinin,
6.5 kDa).
In addition, native mass was obtained by mass spectrome-
try analysis of JcTI-I (0.1 mg/mL) dissolved in water/acetonitrile
(1:1, v/v). The intact mass spectra was acquired in a Synapt G1
HDMS Acquity UPLC instrument (Waters Co., Milford, MA,
USA) programmed with a RF offset (MS proﬁle) adjusted such
that the LC/MS data were effectively acquired from m/z 400
to 3,000, which allowed to obtain multiply charged mass ions.
Analysis was performed using a nanoelectrospray ionization in
positive ion mode (ESI+) and a NanoLockSpray source. For all
measurements, the mass spectrometer was operated in the “V”
mode with a resolving power of at least 10,000 m/z. The data
collection was performed using MassLynx 4.1 software (Waters
Co., Milford, MA, USA) and charge distribution spectra were
then deconvoluted by the Maximum Entropy Technique (Max-
Ent). To assess whether JcTI-I is composed of subunits covalently
linked by disulphide bridges it was previously treated with 0.1 M
DTT followed by 0.3 M iodoacetamide and trypsin digestion to
be analyzed by capillary liquid chromatography/nanoelectrospray
ionization tandem mass spectrometry (ESI–LC–MS/MS), using
the same equipment as described above, coupled with a nano-
high-performance liquid chromatography (UPLC) unit (Waters
Co., Milford, MA, USA). The reduced and alkylated JcTI-I was
injected using the nanoAcquity UPLC sample manager and the
chromatographic separation was performed using an UPLC C18
column (75 μm × 10 cm) with a ﬂow of 0.35 μL/min. The
mass spectra were acquired using a data-dependent acquisition
(DDA) methodology, where the three top peaks were subjected
to MS/MS. Mobile phases A and B consisted of 0.1% formic
acid in water and 0.1% formic acid in acetonitrile, respectively.
Column was equilibrated with 3% solution A and the gradient
conditions used were as follows: 3–40% B for 20 min, 40–70%
B for 40 min, 70% for further 50 min and 70-3% of B for
10 min. The data were processed using the Protein Lynx Global
Server (Waters Co., Milford, MA, USA) software and the searches
made with the assumption that there was a maximum of one
missed trypsin cleavage, peptides were mono-isotopic, methio-
nine residues were partially oxidized and cysteine completely
carbamidomethylated.
Carbohydrate content
The neutral sugar content of JcTI-I-I was estimated by the method
of Dubois et al. (1956) using galactose as standard. To 250 μL of
JcTI-I-I (0.20 mg/mL), 250 μL of phenol 5% (v/v) and 1.25 mL of
concentrated sulfuric acid were added. The mixture was stirred
and left at 25◦C for 30 min. Readings were taken at 490 nm.
The carbohydrate content was estimated based on a calibration
curve built with different concentrations of galactose. The value is
expressed in percentage (%) of carbohydrate per protein mass. To
conﬁrm the presence of covalently bound carbohydrate in JcTI-I a
speciﬁc staining of the protein bands after SDS-PAGE was carried
out (Zacharius et al., 1969). Brieﬂy, after the electrophoresis run
the gel was ﬁxed in a solution of 7.5% (v/v) acetic acid for 2 h,
followed by incubation in a solution of 0.2% (v/v) periodic acid,
at 4◦C for 45 min and incubation with the Schiff reagent at 4◦C for
further 45 min. The glycoprotein nature of the band was revealed
by immersion of the gel in a solution of 0.5% (m/v) potassium
metabisulﬁte in 0.05 M HCl.
N-terminal sequence analysis
This was established in a Shimadzu PPSQ-10 Automated Protein
Sequencer performing Edman degradation. Phenylthiohydantoin
(PTH) amino acids were detected at 269 nm after separation on a
reversed phase C18 column (4.6 mm × 2.5 mm) under isocratic
conditions, according to the manufacturer’s instructions. Percent-
age sequence identity with trypsin inhibitors was searched for
automatic alignment, performed using the NCBI-BLAST search
system (Altschul et al., 1990).
Effect of temperature, pH, and salt
This was evaluated according to Klomklao et al. (2011). JcTI-I
(0.035 mg/mL) was diluted with distilled water to obtain 60–70%
trypsin inhibition. For thermal stability assay, JcTI-I aliquots were
incubated at 90◦C for 0, 10, 20, 30, 40, 50, 60, 90, and 120 min
and then cooled in ice-water. The trypsin inhibitory activity was
determined and reported as the percentage of the residual activ-
ity compared to 70% trypsin inhibition. The effect of pH on
JcTI-I stability was evaluated by measuring the residual activity
after incubation at various pH values for 30 min at 25◦C. The
buffers used were: 0.05 M glycine-HCl, pH 2.2; 0.05 M sodium
acetate, pH 5.2; and 0.1 M sodium borate, pH 10.0. The stability
of JcTI-I to salinity was tested by incubating the trypsin inhibitor
in NaCl solutions ranging from 0% up to 3% (m/v) concentration,
at 25◦C for 30 min. After treatment the inhibitory activity against
trypsin was determined as previously described and the residual
inhibitory activity reported.
Enzyme speciﬁcity
The papain inhibitory assay was performed as described by Abe
et al. (1992), using BANA as substrate. The enzyme concentration
used was established based on a dependent concentration assay
and was that producing an absorbance between 0.25 and 0.30 in
the enzymatic assay and reaction rate corresponding to ½Vmax.
To 60 μL of papain (0.02 mg/mL in 0.25 M sodium phosphate
buffer, pH 6.0), 40 μL of the activation solution (2 × 10−3 M
EDTA + 3 × 10−3 M DTT, pH 6.0), 200 μL of JcTI-I, and 200 μL
of 0.25 M sodium phosphate buffer, pH 6.0, were added. The
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mixture was incubated for 10 min at 37◦C. The reaction was ini-
tiated by addition of 200 μL 0.001 × 10−3 M BANA, prepared
in 1% (v/v) dimethyl sulfoxide (DMSO) and 0.025 M sodium
phosphate buffer, pH 6.0. After 20 min at 37◦C, the reaction
was stopped by addition of 500 μL 2% (v/v) HCl in 95% (v/v)
ethanol. The color product was developed by adding 500 μL
of 0.06% (m/v) DMACA in ethanol and the absorbance was
measured at 540 nm. The chymotrypsin inhibitory activity was
measured by the method of Erlanger et al. (1961), using azocasein
as substrate. Twenty microliters of chymotrypsin (0.1 mg/mL in
2.5 × 10−3 M HCl) was pre-incubated with JcTI-I (0.2 mg/mL)
and 380 μL of 0.05 M Tris–HCl pH 7.5, for 15 min, 37◦C.
Next, 1% (m/v) azocasein was added to the mixture and incu-
bated for 30 min. Reaction was stopped by addition of 300 μL
20% (v/v) TCA. After centrifugation (10,000 × g, 10 min, 25◦C),
aliquots were withdrawn from the supernatants and added to 2 M
NaOH, in an appropriate proportion, and the absorbance taken at
440 nm.
IC 50 value and kinetic studies
The amount of JcTI-I needed for 50% inhibition of trypsin activ-
ity was determined as previously described in Section “Trypsin
Inhibition Assay,” but using the inhibitor in the concentration
range of 1.0 × 10−7 to 2.0 × 10−7 M. Kinetic studies of pro-
tease inhibition by JcTI-I were conducted according to Bijina
et al. (2011), with minor modiﬁcations, using bovine trypsin
(molecular weight 23.3 kDa) and different concentrations of
BAPNA (8.0 × 10−5 to 1.6 × 10−3 M). To calculate the kinetic
parameters, JcTI-I at 5 × 10−7 and 10 × 10−7 M concentra-
tions and 8.0 × 10−6 M trypsin were previously incubated in
0.05 M Tris–HCl/0.02 M CaCl2, pH 7.5, for 10 min, at 37◦C, to
reach the assay temperature. Then, 100 μL fractions of JcTI-I
were added to 10 μL of the trypsin solution and further incu-
bated for 10 min, at 37◦C. Next, both the trypsin solution and
trypsin + JcTI-I mixture were added separately to the BAPNA
solutions and incubated at 37◦C, for 15 min. Reaction was
stopped by addition of 120 μL of 30% (v/v) acetic acid. The
release of p-nitroanilide by the action of trypsin on BAPNA was
measured at 410 nm as before. The velocity of enzyme reac-
tion (v) was determined from progress curves using different
BAPNA concentrations on the base of product concentrations
measured at 410 nm at a ﬁxed time of a reaction. To calcu-
late Km (Michaelis–Menten constant) and Vmax (maximal rate)
of the reaction and to study the pattern of inhibition, data
were plotted as a function of BAPNA concentration using the
usual non-linear curve ﬁtting of Michaelis–Menten and linear
Lineweaver–Burk, respectively. A secondary plot of 1/Km ver-
sus JcTI-I concentrations was also drawn and the X-intercept
used to calculate the dissociation constant (K i; Cornish-Bowden,
1995).
ANTIMICROBIAL ACTIVITY
In vitro antibacterial activity
The antibacterial activity (Hancock, 2000) of JcTI-I was tested
in vitro against Salmonella enterica, Staphylococcus aureus, Bacil-
lus subtilis, and Pseudomonas aeruginosa. The pathogenic bacteria
were grown to mid-logarithm phase in 5 mL of Mueller–Hinton
broth medium, at 37◦C. JcTI-I, at a 500 μg/mL ﬁnal concentra-
tion,was prepared in 0.25M sodiumphosphate buffer, pH7.5, and
sterilized using a 0.22 μm membrane, was incubated in 96-well
ﬂat microplates (Nunc) with 100 μL of each bacterial suspension
(105–106 CFU/mL) dissolved in the growth broth for 4 h at 37◦C.
Bacterial growth was monitored at 630 nm, every hour within the
incubation period, using an automated microplate reader (Bio-
TekElx800). The cell growth of both bacteria in the absence of
JcTI-I was monitored as a blank control. Experiments were run
in triplicate. To determine the minimum inhibitory concentration
(MIC), JcTI-I, at 5–500 μg/mL concentration, was dissolved in
0.25 M sodium phosphate buffer, pH 7.5 and 100 μL incubated
with equal volume of the bacterial cell suspension (105–106 CFU)
in wells of a 96-well polypropylene plate. The plates were kept for
4 h at 37◦C and absorbance readings recorded at 630 nm every
hour.
Activity of JcTI-I against the Salmonella enterica and
Staphylococcus aureus proteases
The capacity of JcTI-I to inhibit the secreted and endogenous bac-
terial proteases was done following the methodology described by
Lima et al. (2011) with minor modiﬁcations. Salmonella enterica
and Staphylococcus aureus were cultured in 5 mL of Mueller-
Hinton broth overnight, at 37◦C, and subcultured in 300 mL of
Mueller-Hinton broth, at 37◦C and 240 rpm, until the log phase
was reached, as measured at 630 nm (Bio-TekElx800 reader). The
bacterial cell cultures were collected at the late exponential growth
phase by centrifugation at 4,000 × g, for 15 min, at 4◦C and the
pellet resuspended in the protease extraction solution [HCl 0.1%
(v/v) + 5.0 × 10−3 M Tris + 5.0 × 10−3 M CaCl2 + 0.1% (v/v)
Triton X-100, pH 7.5] and incubated in ice bath for 15 min. Freez-
ing and thawing took place three times, followed by centrifugation
at 4,000 × g, for 30 min, at 4◦C. The supernatants obtained, con-
taining the protease from Salmonella enterica and Staphylococcus
aureus, were pooled separately for every bacterium species and the
serine protease activity as well as the inhibitory activity of JcTI-I
assayed, according to the method previously described, using azo-
casein as substrate, bovine trypsin and PMSF as serine protease
control inhibitor.
HEMOLYTIC ACTIVITY ASSAY
The hemolytic assay, performed in triplicate, was carried out
as previously described (Kim et al., 2006), with minor modiﬁ-
cations. Human red blood cells were collected in the presence
of heparin, washed three times with phosphate-buffered saline
(PBS; 3.5 × 10−2 M phosphate buffer containing 0.15 M NaCl,
pH 7.0) and recovered by centrifugation in the same buffer. The
hemolytic activity of JcTI-I at 5–500 μg/mL concentration was
evaluated by measuring the release of hemoglobin from fresh
human erythrocytes. Aliquots (25 μL) of a 2.5% suspension
of red blood cells were transferred to 96-well plates and incu-
bated with 25 μL of JcTI-I for 30 min, at 37◦C followed by
centrifugation at 5,000 × g, for 5 min. Hemolysis (%) was deter-
mined by measuring the supernatant absorbance at 540 nm. PBS
(0.05 M, pH 7.4) and 0.1% (v/v) Triton X-100 were used, respec-
tively, as negative (0% hemolysis) and positive (100% hemolysis)
controls.
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TOXICITY ASSAY
The toxicity assaywas reviewed and approved by theAnimal Ethics
Committee (CEPA) of UFC, Brazil, and realized according to the
methodology described byVasconcelos et al. (1994). Toxic activity
was deﬁned as mortality observed in Swiss mice within 24 h after
intraperitoneal injections of JcTI-I at varied concentrations.
STATISTICAL ANALYSIS
The results are expressed as the mean ± SEM. The statistical anal-
ysis was performed by one-way analysis of variance (ANOVA)
followed by Tukey’s multiple comparison tests. The results were
considered to be signiﬁcant at P < 0.05.
RESULTS
PURIFICATION OF JcTI-I
Puriﬁcation of JcTI-I encompassed TCA precipitation of the J.
curcas protein extract followed by two additional chromatogra-
phy steps. TCA, at 2.5% (v/v) ﬁnal concentration, precipitated
the proteins with a recovery of up to 35.6% and 29.0-fold puriﬁ-
cation of the trypsin inhibitor compared to the protein extract
(Table 1). This TCA precipitated fraction was chromatographed
on a trypsin-Sepharose 4B afﬁnity column and the adsorbed pro-
teins, eluted with 0.1 M HCl, concentrated the inhibitory activity
that was speciﬁc for trypsin (Figure 1A), indicating that this
chromatography step was important to exclude other protease
inhibitors also present in the TCA precipitated fraction, as for
papain (data not shown). At this stage, the trypsin inhibitor was
puriﬁed to 331.5-fold with a protein yield of 1.8% and speciﬁc
activity of 6.63 × 10−3 TIU/mg protein (Table 1). The fraction
obtained from the trypsin-Sepharose 4B afﬁnity chromatography
displaying trypsin inhibitory activity was composed of multiple
protein bands as evaluated by SDS-PAGE (Figure 1A; insert: lane
3). Therefore, this fraction was further puriﬁed on a Sephacryl S-
200 column (Figure 1B). The eluted protein present in the major
peak showed a speciﬁc activity of 28.35 × 10−3 TIU/mg pro-
tein, 1417.5-fold puriﬁcation, but a low protein yield of 1.2%.
Nevertheless, it was homogeneous by SDS-PAGE as it presented
a unique protein band with a relative molecular mass around of
20.0 kDa (Figure 1B, insert: lane 2). This puriﬁed protein is a
trypsin inhibitor of J. curcas seed cake thatwas denominated JcTI-I
thereafter.
CHARACTERIZATION OF JcTI-I
Molecular mass determination, pI, carbohydrate content, and
N-terminal sequence
Native molecular mass of JcTI-I was assessed by gel ﬁltration chro-
matography on Sephacryl S-200 column. A molecular mass of
20.2 kDa was calculated for the inhibitor dissolved in 0.05 M
Table 1 | Purification steps of a trypsin inhibitor from J. curcas cake.
Steps Total proteina (mg) Total activityb
(TIU × 10-3)
Specificity activity
(TIU/mg protein × 10-3)
Yieldc (%) Purification
indexd
Crude extract 165.6 4.1 0.02 100 1.0
F2.5 (TCA) 59.0 34.4 0.58 35.6 29.0
Trypsin-Sepharose 4B 3.0 19.9 6.63 1.8 331.5
Sephacryl S-200 2.0 56.7 28.35 1.2 1417.5
Results are presented as mean values of three replications.
aThe total amount of protein recovered from 1 g of defatted ﬂour from J. curcas seed cake.
bOne trypsin inhibitory activity unit (TIU) was deﬁned as the decrease in 0.01 U of absorbance per 15 min assay, at 37◦C.
cThe recovery of protein at each puriﬁcation step (crude extract, 100%).
dPuriﬁcation index is calculated as the ratio between the speciﬁcity activity obtained at each puriﬁcation step and that of the crude extract taken as 1.0.
FIGURE 1 | JcTI-I purification. (A) Afﬁnity-chromatography (Trypsin-
Sepharose 4B column). Inset: SDS-PAGE: (1) molar mass markers; (2) crude
extract; (3) 2.5%TCA fraction; (4) unbound fractions; (5) bound fractions.
(B) Size exclusion chromatography (Sephacryl S-200 column) of JcTI-I puriﬁed
after chromatography onTrypsin-Sepharose 4B column. Inset: SDS-PAGE:
(1) molar mass markers; (2 and 3) JcTI-I (5 μg) in the absence and presence of
1% β-mercaptoethanol, respectively; (4) JcTI-I (5 μg) stained with Schiff’s
reagent.
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sodium phosphate buffer, pH 7.5, containing 0.2 M NaCl. This
value is very similar compared to the molecular mass obtained
by SDS-PAGE in the absence of reducing agents (Figure 1B,
insert: lane 2). However, ESI mass spectrometry under native
conditions, with JcTI-I dissolved in water/acetonitrile (1:1, v/v),
revealed a 10.252 kDa polypeptide (Figure 2A) which is very
close to the molecular mass of JcTI-I found under denatur-
ing condition in the presence of β-mercaptoethanol (Figure 1B;
insert: lane 3) and after two-dimensional (2D) gel electrophore-
sis that also showed a pI of 6.6 (data not shown) for the
FIGURE 2 | Mass spectrometry analysis of JcTI-I. (A) Native JcTI-I;
(B,C) JcTI-I previously reduced and alkylated with DTT and iodoacetamide,
respectively.
puriﬁed inhibitor. DTT reduced and alkylated JcTI-I produced
two derived peptides of 7.133 and 3.124 kDa, after MS/MS
analysis, suggesting that these polypeptides are linked by disul-
ﬁde bond (Figures 2B,C, respectively). Moreover, JcTI-I has
6.4% covalently linked carbohydrate (Figure 1B; insert: lane 4)
and an N-terminal sequence of VRDICKKEAERRDLSSCENY-
ITQRRGY (Table 2). This sequence was conﬁrmed after mass
spectrometry analysis of JcTI-I (Table 3). Alignment of this
N-terminal sequence with known sequences in the NCBI non-
redundant database showed 68 and 58% similarity with an
allergenic 2S albumin from J. curcas seeds and with an albu-
min 2S from Ricinus communis, respectively. In addition, other
peptide sequences were obtained similar to 2S albumins, par-
ticularly from R. communis (Table 3). However, no similarity
was found between the N-terminal sequence of JcTI-I generated
by Edman degradation and the peptide sequences obtained by
MS/MS analysis with known members of the protease inhibitor
family.
Thermal and pH stability
Heating of JcTI-I at 90◦C for up to 20 min induced a slight
increased in the inhibitory activity upon trypsin as compared
to 70% trypsin inhibition of the native inhibitor (Figure 3A).
Afterward the heat treatment for up to 120 min had little conse-
quence on the inhibitory effect of JcTI-I as it was reduced only
to around 4–5% of that of the untreated inhibitor. Incubation
of JcTI-I at the pH range of 2.0–10.0 (Figure 3B) had overall
a slight inducing effect (10%) on inhibition (Figure 3B), except
at pH 5.0 that maintained 70% trypsin inhibition. Incubation
of JcTI-I with different concentrations of salt (0–3%) showed
that the protein retained approximately its original activity up
to 2.0% NaCl concentration (Figure 3C). However, at 2.5% NaCl
concentration an 11.6% reduction in the inhibitory activity was
noticed (Figure 3C), whereas at 3.0% the trypsin inhibition was
10% higher than the 70% inhibition induced by the untreated
inhibitor.
Enzyme speciﬁcity
JcTI-Iwas speciﬁc for inhibiting bovine trypsin, but did not inhibit
signiﬁcantly chymotrypsin and papain.
IC 50 value and kinetic parameters
The data obtained for the studies conducted on protease–
protease inhibitor interaction is depicted in Figure 4. The
amount of inhibitor needed for 50% trypsin inhibition (IC50) was
1.25 × 10−6 M. Moreover, it is calculated that the stoichiometry
of trypsin–protease inhibitor interaction is 1:1.7. Kinetic studies
of inhibition of trypsin by JcTI-I showed that plots of a ﬁxed
concentration of trypsin (8.0 × 10−6 M) preincubated with the
buffer alone (control) and with 0.5 and 1.0 × 10−6 M of JcTI-I
produced different slopes of 1/v versus 1/[s] (Figure 5). These
data indicated a non-competitive mechanism of action of JcTI-I
as lines are converging to the same point on the 1/[S] axis where
Km is unchanged, whereas Vmax is reduced. Furthermore, cal-
culated K i (Figure 5, insert) was on average 0.24 × 10−6 M,
indicating that inhibition of the trypsin hydrolysis by JcTI-I
occurred at very low concentration characterizing a very potent
inhibitor.
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy January 2014 | Volume 5 | Article 5 | 6
“fmicb-05-00005” — 2014/1/28 — 19:59 — page 7 — #7
Costa et al. Antibacterial trypsin inhibitor from Jatropha
Table 2 | Comparison of N-terminal sequence of JcTI-I with similar protein sequences.
Protein Species N-terminal sequence Identity (%) Access numbera
JcTI-I Jatropha curcas VRDICKKEAERRDLSSCENYITQRRGY C0HJF7b
Jat c 1c Jatropha curcas VRDKCGEEAERRTLXGCENYISQRR 68
Precursor albumin 2S Ricinus communis CRQEIQRKDLSSCEQYIRQSSSRR 58 XP_002522851
Glycine-rich protein Arabidopsis thaliana DIAKKKTKKKDLSSSDNYFTKR 55 NP_683354
Short chain of napin-like peptide Ricinus communis CRQEVQRKDLSSCERYLRQSSSRR 54 AAB50869
Short chain of napin-like peptide Momordica charantia REQLRSCESFLRQSRGY 53 AAB50872
aResults of a BLAST search.
bUniProt accession number of JcTI-I.
cDeduced amino acid sequence of Jat c 1b, a allergenic 2S albumin (Maciel et al., 2009).
Table 3 | Peptide sequences of JcTI-I identified after data-dependent acquisition (DDA) analysis.
m/z Charge Delta (ppm) Sequence Modifications
821.3901 2 4.091931 (R)RDLSSCENYITQR(R) Carbamidomethyl C (6)
743.3438 2 10.359877 (R)DLSSCENYITQR(R) Carbamidomethyl C (5)
424.7177 2 −2.8809798 (K)ELSAICR(C) Carbamidomethyl C (6)
646.3268 2 7.850316 (R)CESIHYLLEK(Q) Carbamidomethyl C (1)
774.3472 2 2.6834285 (K)QLEEGEVGSEDEAR(R)
ANTIMICROBIAL ACTIVITY OF JcTI-I
JcTI-I did not affect the growth of Bacillus subtilis and Pseu-
domonas aeruginosa, even at a concentration of 500 μg/mL (data
not shown). However, the protein inhibited the growth of Staphy-
lococcus aureus and Salmonella enterica at all concentrations tested
when compared to controls. The MIC was calculated as 5 μg/mL
for both bacteria (Figures 6A,B). Moreover, JcTI-I caused 84.6%
and almost 100% inhibition of the proteases extracted from
Staphylococcus aureus and Salmonella enterica, respectively, val-
ues similar to that found for protein sparing modiﬁed fast (PSMF;
Figure 7).
ASSESSMENT OF HEMOLYTIC ACTIVITY OF JcTI-I
JcTI-I did not promote hemolysis of human erythrocyte under the
experimental conditions tested (Figure 8).
ASSESSMENT OF TOXIC ACTIVITY OF JcTI-I
JcTI-I did not display toxic activity tomice, even at a concentration
100 times greater than the MIC for Staphylococcus aureus and
Salmonella enterica.
DISCUSSION
Puriﬁcation of a novel trypsin inhibitor (JcTI-I) from J. curcas
seeds cakewas achieved byTCAprecipitation of the protein extract
followed by two chromatographic steps. JcTI-I is a 10.252 kDa
neutral glycosylated protein with a pI of 6.6 and 6.4% of carbo-
hydrate. Both the molecular mass and pI are similar to other seed
trypsin inhibitors previously characterized as, for example, the
10.0 kDa trypsin inhibitor from Zea mays (Baker et al., 2009) and
that puriﬁed from Phaseolus limensis seeds, with pI of 7.6 (Wang
and Rao, 2010).
Analyzing the results of both SDS-PAGE andMS/MS, it appears
that the 10.252 kDa JcTI-I molecule is composed of a 7.133 and
3.124 kDa polypeptides jointed together by at least one disul-
phide bridge and that DTT + iodoacetamide treatments, but not
β-mercaptoethanol alone, were able of irreversibly splitting the
molecule in the small and large subunits. The results of size exclu-
sion chromatography of JcTI-I on Sephacryl S-200 gave a 20.2 kDa
molecule. It is plausible that under such mild conditions in which
JcTI-I was dissolved in 0.050 M sodium phosphate buffer contain-
ing 0.2 M NaCl, pH 7.5, the 10.252 kDa monomer associated to
form a 20.2 kDa dimer, which does not occur in the presence of
acetonitrile in the MS/MS analysis.
Alignments of JcTI-I sequence with other protein sequences
showed that the highest similarity was veriﬁed with Jat c 1, a
J. curcas allergen that belongs to the 2S albumin family (Maciel
et al., 2009), but not with known protease inhibitor sequences.
Several trypsin inhibitors show sequence similarities with the 2S
albumin-like proteins, as two barley Bowman–Birk type trypsin
inhibitor isoforms and the trypsin inhibitor of Brassica juncea
seeds (Terras et al., 1993; Mandal et al., 2002). Therefore, JcTI-I
might be a novel trypsin inhibitor that belongs to the 2S albumin
family.
Protease inhibitors exhibit a considerable stability to high
temperatures and to large pH variations (Bhattacharyya et al.,
2006; Bijina et al., 2011). JcTI-I has also these common prop-
erties as it was active and stable after incubation at 90◦C for
60 min and in the pH range 2.0–10.0, in agreement with
other plant protease inhibitors. Moreover, JcTI-I was stable to
high salt concentrations as it retained full activity after treat-
ment with up to 2% NaCl. The trypsin inhibitor puriﬁed
from adzuki bean (Vigna angularis) seeds was also stable when
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FIGURE 3 |Trypsin inhibitory activity assay of JcTI-I at pH 7.5, at room
temperature (around 25◦C) after: (A) heat-treatment; (B) incubation at
pH 2–10 for 30 min; (C) incubation with 0–3 M NaCl concentration.
Each point represents the mean of three estimates. The standard deviation
was less than 10%.
FIGURE 4 | Stoichiometry of the JcTI-I-protease interaction. Bar
indicates standard deviation from triplicate determinations.
FIGURE 5 | Lineweaver–Burk plot (1/v × 1/[S]) of the inhibition of
trypsin by JcTI-I, at two different inhibitor concentrations, in
conjunction with the Dixon plot (1/v × [I], insert) for identification of
Km, K i and the likely mechanism of enzyme inhibition. Each point
represents the mean of three estimates. The standard deviation was less
than 10%.
incubated with NaCl up to 3% concentration (Klomklao et al.,
2011). Such stability was associated to disulphide bridges that
are presumably responsible for the functional stability of Kunitz
type protease inhibitors in the presence of physical and chem-
ical denaturants such as temperature, pH, and reducing agents
(Kridric et al., 2002).
JcTI-I is a non-competitive trypsin inhibitor similar to other
trypsin inhibitors, such as AETI, APTI, and TTI from the
seeds of Archidendron ellipticum (Bhattacharyya et al., 2006),
Adenanthera pavonina (Macedo et al., 2004), and Tamarindus
indica (Araújo et al., 2005), respectively. The IC50 of JcTI-I
for trypsin was 1.25 × 10−6 M, indicating that it was more
potent than EvTI, the trypsin inhibitor from Erythrina velutina
seeds (IC50 = 2.2 × 10−6 M; Machado et al., 2013) and less
than SSTI2, the trypsin inhibitor from Sapindus saponaria seeds
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FIGURE 6 | Effect of JcTI-I at different concentrations on the growth of
Staphylococcus aureus (A), and Salmonella enterica (B). Control:
0.05 M sodium phosphate buffer (pH 7.5). The minimal inhibitory
concentration (MIC) of JcTI-I was determined based on these data. Assay
was done in triplicate for every inhibitor concentration. The standard
deviation was less than 10%.
(IC50 = 8.3 × 10−8 M; Macedo et al., 2011). JcTI-I interac-
tion with trypsin occurred at the 1:1.7 molar ratio, indicating
a 1:2 stoichiometry, with two equivalent binding sites. Sim-
ilar result was found for a protease inhibitor from Moringa
oleifera leaves (Bijina et al., 2011). The inhibition constant (K i)
for JcTI-I was 2 × 10−11 M under the assay conditions. Low
K i values were also found for the trypsin inhibitors CBTI-2
from Caesalpinia bonduc (Bhattacharyya et al., 2007) and AETI
(Bhattacharyya et al., 2006) with K i of 2.4 and 2.7 × 10−10 M,
respectively.
Resistance of some strains of Gram-positive andGram-negative
bacteria to conventional antibiotics has increased dramatically
caused or induced by the widespread misuse and overuse of
antibiotics and represents a serious threat to public health world-
wide. Therefore, discovery and/or development of alternative,
FIGURE 7 | Inhibitory effect (%) of JcTI-I on the proteases extracted
from Staphylococcus aureus and Salmonella enterica. Asterisks
represent signiﬁcant difference (P < 0.05) in comparison to control (0.25 M
sodium phosphate buffer, pH 7.5). The experiments were run in triplicate
and each value is presented as mean ± standard deviation.
FIGURE 8 | Assessment of the hemolytic effect of JcTI-I on human
erythrocytes. A suspension of washed human erythrocytes was incubated
with various concentrations of JcTI-I (--). Values (OD540) were normalized
against 100% lysed erythrocytes (0.1%Triton X-100) (-•-). Control was the
red cells incubated with 0.05 M PBS, pH 7.4 (--). Each point represents
the mean of three estimates. The standard deviation was less than 10%.
non-conventional drugs with activity against most resistant bac-
teria for infection control are of paramount importance (Lima
et al., 2011). J. curcas is a plant traditionally used for medici-
nal purposes and its antimicrobial potential has been previously
reported. Indeed, extracts from leaves, root barks, latex, and var-
ious fruit parts of J. curcas showed inhibitory activity against E.
coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Bacil-
lus subtilis (Arekemase et al., 2011; Nyembo et al., 2012; Rachana
et al., 2012). However, few reports are related to the antimicro-
bial activity of compounds present in the seed cake of J. curcas,
although its potential use as a source of antibacterial agents has
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been suggested (Sriprang et al., 2010; Sundari and Selvaraj, 2011).
The seed cake of J. curcas represents an attractive raw mate-
rial to extract novel antibacterial drugs because it is produced
in large scale as a waste material after oil extraction to produce
biodiesel. It is estimated that 1-tn per day of J. curcas extracted
oil generates, approximately, 3 tn of seed cake (Srividhya et al.,
2010).
The use of protease inhibitors as novel therapeutics has pre-
viously been proposed (Bhattacharjee et al., 2012; Machado et al.,
2013). Therefore, take into consideration the huge amount of
J. curcas seed cake generated, from which JcTI-I was puriﬁed,
the hypothesis that it could behave as a natural drug against
human pathogens was also tested. This was experimentally con-
ﬁrmed as JcTI-I behaved as a potent inhibitor of Staphylococcus
aureus and Salmonella enterica growth. The MIC of JcTI-I for
both bacteria was 5 μg/mL. This concentration is sixfold lower
compared with that found for a potato inhibitor effective against
various bacteria, including Staphylococcus aureus with a MIC
around 30 μg/mL (Kim et al., 2006), about 50-fold lower than
that of Xb-KTI, a kunitz proteinase inhibitor from X. blandum
corms, active against Salmonella typhimurium, with a MIC of
about 256 μg/mL (Lima et al., 2011) and about 25-fold lower
than that of cloxacillin, a β-lactam antibiotic used as ther-
apeutic drug against MRSA with a MIC around 128 μg/mL
(Islam et al., 2008). According to Hancock (2000), the best pro-
tein/peptide candidates for antibacterial drugs have MICs ranging
from 1 to 8 μg/mL. Based on these results, JcTI-I can be con-
sidered as a potent inhibitor of bacterial growth and could be
explored as an antibiotic protein to help bring down the 10–
30% mortality caused by Staphylococcus aureus (van Hal et al.,
2012).
Serine proteases have been implicated in the virulence of some
bacterial strains (Speranskaya et al., 2006; Tripathi et al., 2011).
Therefore, substances that can interfere with the proteolytic activ-
ity of these enzymes, like protease inhibitors, could be an effective
strategy to combat bacterial infections (González-Lamothe et al.,
2009). JcTI-I did have inhibitory activity against the serine pro-
teases from the tested bacteria. It caused about 85 and 100%
inhibition of the proteases extracted from Staphylococcus aureus
and Salmonella enterica, respectively, values compared to those
achieved by PSMF,a synthetic inhibitor. These results are similar to
that reported by Lima et al. (2011) who found that Xb-KTI caused
about 80% inhibition of the serine proteases from Salmonella
typhimurium.
To assess whether JcTI-I promotes lysis of eukaryotic cells, this
protease inhibitor was incubated with human erythrocytes up to
the concentration of 500 μg/mL, about 100-fold higher than the
MICof JcTI-I (5μg/mL) for bothbacteria. Even at such concentra-
tion, JcTI-I does not lysis the red cells. This result suggests that the
mode of action of JcTI-I is not by disrupting cell membranes and
it does not have toxic effects toward mammalian cells. In addition,
JcTI-I was not toxic to mice at a concentration very much higher
than the MIC for Staphylococcus aureus and Salmonella enterica.
In summary, we have isolated, puriﬁed, and characterized a
novel trypsin inhibitor from J. curcas seed cake, named JcTI-I,
which possesses a potent activity against the human pathogenic
bacteria Staphylococcus aureus and Salmonella enterica. The lack
of hemolytic activity against human erythrocytes and toxic activity
to mice together with resistance to heat treatment, pH, high salt
concentrations, and putative resistance to proteases make JcTI-I a
pharmacologically interesting and valuable drug for the design of
a novel antibiotic medicament.
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